MSP-2017 (etripamil)

etripamil · Milestone Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSP-2017 (etripamil), covering 2020-12-30 to 2020-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm [Phase 2]